Prevention & Chronic Conditions

Broadcast

New Horizons in Dyslipidaemia

Peter Libby, Kausik Ray, Erik Stroes

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Effects of S/V Therapy on Exercise Capacity in Patients with HFrEF

Published:

19 May 2023

Citation:

Cardiac Failure Review 2023;8:e07.

Epicardial Fat in HFpEF: Correlation or Causation?

Published:

15 April 2023

Citation:

Cardiac Failure Review 2023;9:e06.

Heart Failure and Cardiac Rehabilitation

Published:

23 September 2022

Citation:

Cardiac Failure Review 2022;8:e28.

SGLT2i in HFpEF

Published:

08 July 2022

Citation:

Cardiac Failure Review 2022;8:e26.